About US
Contact us
>>Back
Breckenridge receives final FDA approval for Letrozole ANDA
- Publisher：
- Publication：2011/6/13
Breckenridge Pharmaceutical, Inc. announced today the immediate launch of Letrozole 2.5 mg Tablets.
The U.S. Food and Drug Administration granted final approval for the Abbreviated New Drug Application (ANDA) for this product, which is being supplied under a licensing agreement.
Letrozole Tablets are AB rated to Femara®, a $700 million dollar oncology drug marketed by Novartis.
SOURCE Breckenridge Pharmaceutical, Inc.